GERN

Geron Corporation

4.68 USD
+0.08 (+1.74%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Geron Corporation stock is up 0.65% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.43% of the previous 28 July’s closed higher than June. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
11 Jun 16:41 17 Jan, 2025 4.00 CALL 150 11416
11 Jun 18:45 19 Jul, 2024 5.00 PUT 947 12
13 Jun 17:42 20 Dec, 2024 3.50 PUT 3000 3
17 Jun 15:01 20 Dec, 2024 4.50 CALL 300 498
17 Jun 17:49 17 Jan, 2025 3.00 CALL 150 7634
21 Jun 13:48 21 Jun, 2024 3.00 CALL 200 6502
11 Jul 17:01 20 Sep, 2024 5.00 CALL 593 1676
12 Jul 18:11 20 Sep, 2024 2.00 CALL 150 1503
17 Jul 14:35 16 Aug, 2024 4.00 CALL 500 192
18 Jul 18:55 17 Jan, 2025 5.50 PUT 208 411

About Geron Corporation

Geron Corporation focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials. The company was incorporated in 1990 and is headquartered in Foster City, California.